Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
5 pending office actions • 2 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Helix Inc. has 5 pending office actions in the Transportation, E-Commerce & Mechanical Systems technology area. These actions are distributed among 5 distinct examiners and 2 distinct art units. EZEWOKO, MICHAEL I is the busiest examiner, with 1 pending office action currently assigned. With 5 distinct examiners for 5 pending actions, each case is being reviewed by a different official.
The workload is concentrated in 2 distinct art units, indicating that the 5 pending matters fall into two primary technical categories. The busiest examiner pending count of 1 shows that no single examiner is managing more than one action for the company. This arrangement provides a variety of perspectives on the company's technology across 5 distinct examiners. The presence of 2 distinct art units suggests that the filings cover multiple technical sections of the patent office. This structure requires the company to manage interactions with 5 different examiners across 2 separate art units. EZEWOKO, MICHAEL I is one of the 5 distinct examiners handling the pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EZEWOKO, MICHAEL I | 1 | 61.5% | +51.2% |
| SITTON, JEHANNE SOUAYA | 1 | 53.2% | +48.0% |
| WISE, OLIVIA M. | 1 | 33.9% | +29.9% |
| CLOW, LORI A | 1 | 64.2% | +28.5% |
| ELKINS, BLAKE HARRISON | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19362171 | SYSTEMS AND METHODS FOR PROVIDING TEST RESULTS OF GENE SEQUENCING DATA ON A RECURRING BASIS | EZEWOKO, MICHAEL I | — |
| 18470759 | POLYCYSTIC KIDNEY DISEASE DIAGNOSIS AND TREATMENT BASED ON DETECTION OF PKD1/PKD2 VARIANTS | SITTON, JEHANNE SOUAYA | — |
| 18141009 | GENETIC SCREENING TO DETERMINE HEALTH RISKS ASSOCIATED WITH INTERACTING PHENOTYPES | WISE, OLIVIA M. | — |
| 18124670 | MITOCHONDRIAL PROBES FOR ENDOGENOUS CONTROL AND CONTAMINATION DETECTION | CLOW, LORI A | — |
| 18102202 | DIFFERENTIATION OF COINFECTION FROM CONTAMINATION WITHIN GENETIC SAMPLES | ELKINS, BLAKE HARRISON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19362171 | SYSTEMS AND METHODS FOR PROVIDING TEST RESULTS OF GENE SEQUENCING DATA ON A RECURRING BASIS | EZEWOKO, MICHAEL I | — |
| 18470759 | POLYCYSTIC KIDNEY DISEASE DIAGNOSIS AND TREATMENT BASED ON DETECTION OF PKD1/PKD2 VARIANTS | SITTON, JEHANNE SOUAYA | — |
| 18141009 | GENETIC SCREENING TO DETERMINE HEALTH RISKS ASSOCIATED WITH INTERACTING PHENOTYPES | WISE, OLIVIA M. | — |
| 18124670 | MITOCHONDRIAL PROBES FOR ENDOGENOUS CONTROL AND CONTAMINATION DETECTION | CLOW, LORI A | — |
| Art Unit | Apps |
|---|---|
| 3682 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19362171 | SYSTEMS AND METHODS FOR PROVIDING TEST RESULTS OF GENE SEQUENCING DATA ON A RECURRING BASIS | EZEWOKO, MICHAEL I | 3682 | §101§103 | Non-Final OA | — | Pending | Oct 17, 2025 |
| 18470759 | POLYCYSTIC KIDNEY DISEASE DIAGNOSIS AND TREATMENT BASED ON DETECTION OF PKD1/PKD2 VARIANTS | SITTON, JEHANNE SOUAYA | 1682 | §101§103§112 | Final Rejection | — | Pending | Sep 20, 2023 |
| 18141009 | GENETIC SCREENING TO DETERMINE HEALTH RISKS ASSOCIATED WITH INTERACTING PHENOTYPES | WISE, OLIVIA M. | — | §101§103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18124670 | MITOCHONDRIAL PROBES FOR ENDOGENOUS CONTROL AND CONTAMINATION DETECTION | CLOW, LORI A | — | §101§103§112 | Non-Final OA | — | Pending | Mar 22, 2023 |
| 18102202 | DIFFERENTIATION OF COINFECTION FROM CONTAMINATION WITHIN GENETIC SAMPLES | ELKINS, BLAKE HARRISON | — | §101§103§112DP | Non-Final OA | — | Pending | Jan 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial